Jinhai Medical Technology Limited (HKG:2225)

Jinhai Medical Technology Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 9, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	10,580	9,823	3,076	2,681	3,444	1,697
Market Cap Growth	47.22%	219.33%	14.72%	-22.14%	102.90%	-22.91%
Enterprise Value	10,630	9,787	2,986	2,560	3,307	1,591
Last Close Price	2.00	1.90	0.59	0.55	0.70	0.34
PE Ratio	-	-	-	985.27	-	229.10
PS Ratio	44.19	34.35	11.39	20.70	27.20	12.88
PB Ratio	61.79	52.65	13.86	18.75	24.79	11.35
P/TBV Ratio	63.96	55.17	13.87	18.92	24.53	11.35
P/FCF Ratio	-	-	-	150.54	217.95	39.94
P/OCF Ratio	-	-	-	108.73	178.33	39.19
EV/Sales Ratio	44.40	34.23	11.06	19.76	26.11	12.07
EV/EBITDA Ratio	-	-	-	123.30	245.78	125.98
EV/FCF Ratio	-126.88	-	-	143.75	209.28	37.42
Debt / Equity Ratio	0.53	0.44	0.27	0.18	0.08	0.22
Debt / EBITDA Ratio	-	-	-	1.01	0.48	1.25
Debt / FCF Ratio	-	-	-	1.45	0.68	0.76
Asset Turnover	0.68	0.83	0.89	0.60	0.60	0.55
Inventory Turnover	12.26	15.93	22.00	13.28	-	-
Quick Ratio	1.04	1.02	1.77	2.11	2.99	2.42
Current Ratio	1.17	1.29	2.01	2.38	3.24	2.46
Return on Equity (ROE)	-70.57%	-51.96%	-13.25%	0.48%	-2.01%	5.08%
Return on Assets (ROA)	-26.30%	-20.74%	-5.60%	-	-2.45%	-2.82%
Return on Invested Capital (ROIC)	-68.20%	-84.55%	-44.90%	-	-57.15%	-19.05%
Return on Capital Employed (ROCE)	-80.90%	-56.60%	-11.20%	-	-5.90%	-7.10%
Earnings Yield	-1.29%	-1.04%	-0.60%	0.10%	-0.04%	0.44%
FCF Yield	-0.79%	-0.25%	-0.60%	0.66%	0.46%	2.50%
Buyback Yield / Dilution	-1.44%	-4.00%	-1.04%	-	-	-
Total Shareholder Return	-1.44%	-4.00%	-1.04%	-	-	-

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.